Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complex
Phase 2
- Conditions
- tuberous sclerosis complex
- Registration Number
- JPRN-UMIN000002844
- Lead Sponsor
- Department of Dermatology Graduate School of Medicine, Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with severe mental retardation who cannot carry out this treatment plan. 2) Patients with a past history of hypersensitivity to macrolide antibiotics. 3) Patients who were judged unsuitable for this study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in color and size of the skin lesions after 12 weeks topical treatment
- Secondary Outcome Measures
Name Time Method change in shape appearance of contact dermatitis rapamycin levels in whole blood